The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)
Can you apply?
This grant is for NIH-funded research institutions and consortia to establish or maintain a pharmacokinetic (PK) laboratory supporting the Experimental Therapeutics Clinical Trials Network. Eligible applicants include universities, medical centers, hospitals, and research organizations with 501(c)(3) status or federal/state government agencies. The lab must provide pharmacokinetic analysis, consultation, and data support for ETCTN clinical trials. Applicants must demonstrate existing capacity or credible plans to develop specialized laboratory facilities and qualified personnel for drug analysis and clinical trial support.
Support addresses the infrastructure and operational needs of a centralized resource laboratory rather than direct clinical trial conduct. The goal is to advance therapeutics research through reliable, accessible PK analysis services for network-wide trials.
This grant is for NIH-funded research institutions and consortia to establish or maintain a pharmacokinetic (PK) laboratory supporting the Experimental Therapeutics Clinical Trials Network. Eligible applicants include universities, medical centers, hospitals, and research organizations with 501(c)(3) status or federal/state government agencies. The lab must provide pharmacokinetic analysis, consultation, and data support for ETCTN clinical trials. Applicants must demonstrate existing capacity or credible plans to develop specialized laboratory facilities and qualified personnel for drug analysis and clinical trial support.
Support addresses the infrastructure and operational needs of a centralized resource laboratory rather than direct clinical trial conduct. The goal is to advance therapeutics research through reliable, accessible PK analysis services for network-wide trials.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- Colleges (all higher ed)
- Hospital
- Nonprofits
- Private University
- Public University
- Small Business (SBA-defined)
Details
This grant is for NIH-funded research institutions and consortia to establish or maintain a pharmacokinetic (PK) laboratory supporting the Experimental Therapeutics Clinical Trials Network. Eligible applicants include universities, medical centers, hospitals, and research organizations with 501(c)(3) status or federal/state government agencies. The lab must provide pharmacokinetic analysis, consultation, and data support for ETCTN clinical trials. Applicants must demonstrate existing capacity or credible plans to develop specialized laboratory facilities and qualified personnel for drug analysis and clinical trial support.
Support addresses the infrastructure and operational needs of a centralized resource laboratory rather than direct clinical trial conduct. The goal is to advance therapeutics research through reliable, accessible PK analysis services for network-wide trials.
How to apply
Application links
Required documents
- SF-424 (Federal Application for Federal Assistance)
- R&R Budget Form (NIH budget narrative and justification)
- Project Narrative and Research Plan
- Biographical sketches of key laboratory personnel
- Letters of institutional commitment and support
- Evidence of laboratory facilities and equipment capability
- Quality assurance and data management protocols
- Letters of collaboration from ETCTN stakeholders
Funding track record
Recent awards under CFDA 93.395 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$333,720,995
-
$226,323,195
-
$180,463,644
-
$148,820,579
-
$130,290,027
-
$125,672,442
-
$124,513,663
-
$112,462,142
-
$110,600,870
-
$96,205,648
Top States by Funding
- CA 9 awards $710.7M
- PA 5 awards $513.3M
- NY 7 awards $462.6M
- MA 7 awards $282.8M
- IL 3 awards $274.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.395). How funding has trended year over year.
| 2024 | $1,298,551,504 | |
| 2025 | $1,414,965,434 | |
| 2026 est. | $926,626,977 |
FAQ
Who can apply for this grant?
Universities, medical centers, hospitals, and other research institutions with 501(c)(3) nonprofit or government status. Your organization must have relevant laboratory expertise or credible plans to develop PK capabilities.
What is the deadline and application timeline?
Applications open May 8, 2026 and close June 30, 2026. Plan your submission at least 2-3 months in advance to gather institutional support and documentation.
What activities does this fund?
This funds a centralized pharmacokinetic laboratory resource serving the ETCTN. Supported activities include drug analysis, assay development, data interpretation, and consultation services for clinical trials.
How competitive is this program?
This is highly competitive. NIH research infrastructure grants typically require strong preliminary data, clear institutional commitment, and demonstrated capacity. Prior PK laboratory experience strengthens applications significantly.
What is the typical funding range?
Funding amounts vary based on laboratory scope and needs. Budgets should justify all personnel, equipment, supplies, and operational costs for quality PK services.
💡 Tips for applicants
- Clearly describe your laboratory's current capacity, equipment, and qualified personnel for pharmacokinetic analysis.
- Demonstrate a track record of accurate, timely results through prior work or relevant preliminary data.
- Include strong institutional commitment and support letters from leadership endorsing the resource role.
- Detail how your lab will integrate with ETCTN operations and support multiple concurrent clinical trials.
- Address quality assurance, data management, and communication plans for serving the network reliably.
⚠️ Common mistakes
Overstating PK lab capacity without credible preliminary data or equipment inventory. Failing to show institutional commitment through budget allocations and leadership endorsement letters. Underestimating operational costs for sustained, reliable service delivery to a research network.
Similar grants
- OPEN 27-0343-10 FFY27 Local Agency General Non-Enforcement — Illinois Department of Transportation
- ROLLING Annual Agency Threshold Application Applicants for Funding Start Here — Texas City of Austin - Austin Public Health
- CLOSED Virginia’s Black Indigenous and People of Color (BIPOC) Grant – FY26 — Virginia The Virginia Department of Historic Resources
- ROLLING Rail Industrial Access Grant (RIA) — Virginia Department of Rail and Public Transportation
- ROLLING AGR GTA Business Acceleration and Marketing (BAM) Program — Montana Department of Agriculture